Suzan McNamara1, Wilson H Miller. Show Affiliations » 1. Sir Mortimer B. Davis Jewish General Hospital Segal Cancer Center, Montreal, Quebec, Canada.
Abstract
Entities: Chemical Disease
Mesh: See more » BexaroteneClinical Trials as TopicEpigenesis, GeneticHumansLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/geneticsMaximum Tolerated DoseRetinoid X Receptors/antagonists & inhibitorsRetinoid X Receptors/metabolismRetinoids/therapeutic useSignal TransductionTetrahydronaphthalenes/adverse effectsTetrahydronaphthalenes/therapeutic use
Substances: See more » Retinoid X ReceptorsRetinoidsTetrahydronaphthalenesBexarotene
Year: 2008 PMID: 18765520 DOI: 10.1158/1078-0432.CCR-08-1081
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531